NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
NRINX
Price
$29.53
Change
+$0.08 (+0.27%)
Updated
Jul 31 closing price
Net Assets
1.45B
Interact to see
Advertisement

NAESX vs NRINX

NAESX vs NRINX Comparison Chart in %
View a ticker or compare two or three
VS
NAESX vs. NRINX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a Hold and NRINX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. NRINX (1.45B). NAESX pays higher dividends than NRINX: NAESX (1.10) vs NRINX (0.07). NAESX was incepted earlier than NRINX: NAESX (66 years) vs NRINX (8 years). NRINX (0.86) is less costly to investors than NAESX (0.17). NAESX is a more actively managed with annual turnover of: 17.00 vs. NRINX (12.00). NAESX (0) and NRINX (0) have matching initial minimum investment requirements. NRINX annual gain was more profitable for investors over the last year : 36.70 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. NRINX (23.87).
NAESXNRINXNAESX / NRINX
Total Expense Ratio0.170.8620%
Annual Report Gross Expense Ratio0.170.8620%
Fund Existence66 years8 years-
Gain YTD14.56319.65274%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets189B1.45B13,043%
Annual Yield % from dividends1.100.071,511%
Returns for 1 year22.5636.7061%
Returns for 3 years43.3046.3194%
Returns for 5 years34.9523.87146%
Returns for 10 years155.28N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv